Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Summary

Seegene has launched the Global Million Clinical Study enrolling one million test cases to evaluate the clinical utility of syndromic PCR testing and establish disease-specific testing standards through real-world evidence.